J&J slowly building the blocks & leaves very little imagination as to why the collaboration has been formed, the limited information in Janssen / PYC release did i think point towards neurological targets.
Also this bit from the article is interesting -
"And while individual scientists rely on relatively small grants to support projects, a group like this could engage academic groups at top centers such as MIT and Johns Hopkins to undertake some Manhattan Project-style programs on sequencing to truly understand all of the complex biology at work in these diseases."
Phylogica had collaborations / licensing deals with Johns Hopkins & Massachusetts General Hospital not long after listing for the purpose of their genetic screening technology, while i have little doubt that those partnerships are no longer around with nothing heard of for years there still is probably some familiarity with locations.
PYC Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)